A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis

References

• Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488–494.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations. Presse Med. 2013;42:493–498.
   PubMed Web of Science ®Google Scholar
• Kettritz R. How anti‐neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol. 2012;169(3):220–228.
   PubMed Web of Science ®Google Scholar
• Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990;87(11):4115–4119.
   PubMed Web of Science ®Google Scholar
• Charles LA, Caldas ML, Falk RJ, et al. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991;50(6):539–546.
   PubMed Web of Science ®Google Scholar
• Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110(7):955–963.
   PubMed Web of Science ®Google Scholar
• Little MA, Smyth CL, Yadav R, et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood. 2005;106(6):2050–2058.
   PubMed Web of Science ®Google Scholar
• Xiao H, Heeringa P, Liu Z, et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol. 2005;167(1):39–45.
   PubMed Web of Science ®Google Scholar
• Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992;41(2):375–383.
   PubMed Web of Science ®Google Scholar
• Pitanga TN, de Aragão França L, Rocha VCJ, et al. Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells. BMC Cell Biol. 2014;15(1):21.
   PubMedGoogle Scholar
• Savage CO, Pottinger BE, Gaskin G, et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol. 1992;141(2):335–342.
   PubMed Web of Science ®Google Scholar
• Schreiber A, Xiao H, Jennette JC, et al. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol. 2009;20(2):289–298.
   PubMed Web of Science ®Google Scholar
• Huugen D, Van Esch A, Xiao H, et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71(7):646–654.
   PubMed Web of Science ®Google Scholar
• Jayne DRW, Bruchfeld AN, Harper L, et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol. 2017;28(9):2756–2767.
   PubMed Web of Science ®Google Scholar
• Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol. 1997;8(3):386–394.
   PubMed Web of Science ®Google Scholar
• Ralston DR, Marsh CB, Lowe MP, et al. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest. 1997;100(6):1416–1424.
   PubMed Web of Science ®Google Scholar
• Jennette JC. Overview of the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Clin Exp Nephrol. 2013;17(5):603–606.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–1832.
   PubMed Web of Science ®Google Scholar
• Weidner S, Neupert W, Goppelt‐Struebe M, et al. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum. 2001;44(7):1698–1706.
   PubMedGoogle Scholar
• Harper L, Radford D, Plant T, et al. IgG from myeloperoxidase–antineutrophil cytoplasmic antibody–positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3–antineutrophil cytoplasmic antibody–positive patients. Arthritis Rheum. 2001;44(4):921–930.
   PubMedGoogle Scholar
• Heeringa P, Little MA. In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitations. Arthritis Res Ther. 2010;13(1):204.
   Web of Science ®Google Scholar
• Holland M, Hewins P, Goodall M, et al. Anti‐neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol. 2004;138(1):183–192.
   PubMed Web of Science ®Google Scholar
• Lin W, Chen M, Zhao M-H. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis. Autoimmunity. 2009;42(3):198–202.
   PubMed Web of Science ®Google Scholar
• Moura MC, Thompson GE, Nelson DA, et al. Preferential binding of anti-neutrophil cytoplasmic antibodies to an unexpected epitope of a chimeric proteinase 3 mutant. BioRxiv. 2019. 549063.
   Google Scholar
• Yoshida M, Sasaki M, Nakabayashi I, et al. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis. Clin Exp Rheumatol. 2009;27(1):S28.
   PubMed Web of Science ®Google Scholar
• Nakazawa D, Shida H, Tomaru U, et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol. 2014;25(5):990–997.
   PubMed Web of Science ®Google Scholar
• Xu P-C, Chen M, Zhao M-H. High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass. Autoimmunity. 2012;45(3):218–225.
   PubMed Web of Science ®Google Scholar
• Popat RJ, Robson MG. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro. Ann Rheum Dis. 2019;78(5):709–711.
   PubMed Web of Science ®Google Scholar
• Franssen CF, Huitema MG, Kobold ACM, et al. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis. J Am Soc Nephrol. 1999;10(7):1506–1515.
   PubMed Web of Science ®Google Scholar
• Hao J, Meng L-Q, Xu P-C, et al. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One. 2012;7(5):e38317.
   PubMed Web of Science ®Google Scholar
• Xiao H, Dairaghi DJ, Powers JP, et al. C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol. 2014;25(2):225–231.
   PubMed Web of Science ®Google Scholar
• Hu N, Westra J, der Meer BD-V, et al. Decreased Cxcr1 and Cxcr2 expression on neutrophils in Anca-aav increases neutrophil adhesion and impairs transendothelial migration. Clin Exp Immunol. 2011;164:139–140.
   Web of Science ®Google Scholar
• Radford DJ, Luu NT, Hewins P, et al. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum. 2001;44(12):2851–2861.
   PubMedGoogle Scholar
• Sage PT, Carman CV. Settings and mechanisms for trans-cellular diapedesis. Front Biosci. 2009;14(1):5066–5083.
   Google Scholar
• Guo R-F, Ward PA. ROLE OF C5A IN INFLAMMATORY RESPONSES. Annu Rev Immunol. 2005;23(1):821–852.
   PubMedGoogle Scholar
• Muller WA, Luscinskas FW. Assays of transendothelial migration in vitro. Meth Enzymol. 2008;443:155–176.
   PubMed Web of Science ®Google Scholar
• Kraaij T, Kamerling SWA, van Dam LS, et al. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA. Kidney Int. 2018;94(1):139–149.
   PubMed Web of Science ®Google Scholar